The chemical class known as RARRES1 activators encompasses a diverse range of compounds primarily found in or related to the retinoid family, which are known to bind to and activate retinoic acid receptors (RARs) and retinoid X receptors (RXRs). These activators are characterized by their ability to modulate gene expression by influencing the retinoid signaling pathways, which are essential for regulating cell growth, differentiation, and apoptosis. This modulation occurs through the activation of nuclear receptors, which then bind to retinoic acid response elements (RAREs) in the DNA, altering the transcription of target genes, including RARRES1. The activation of RARRES1 is a complex process that involves the interplay of these compounds with the intracellular machinery that governs gene expression.
Within this class, the compounds can differ significantly in structure, ranging from natural derivatives of vitamin A to synthetic analogs specifically designed to engage with the nuclear receptors. Despite this structural diversity, the overarching functionality remains their capacity to engage with the retinoid signaling pathway. Upon binding to their respective receptors, these activators initiate a cascade of intracellular events leading to the modulation of gene expression profiles within the cell. The outcome of such interactions is the upregulation of genes under the control of RAREs, which can include RARRES1. This upregulation is a consequence of the receptor-ligand complex recruiting coactivator proteins and initiating transcription. The precise manner in which these activators influence RARRES1 expression is subject to the specific cellular context, including the abundance of receptors, coactivators, and other regulatory proteins that can affect the efficiency and selectivity of the signaling pathway activation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Tazarotene | 118292-40-3 | sc-220193 | 10 mg | $103.00 | ||
A topical retinoid prodrug converted to its active form by esterases in the skin, which binds to retinoic acid receptors and could possibly activate RARRES1 expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
The active metabolite of Vitamin A, binding to retinoic acid receptors and could possibly activate RARRES1 expression as part of the retinoid signaling cascade. | ||||||
13-cis-Retinoic acid | 4759-48-2 | sc-205568 sc-205568A | 100 mg 250 mg | $75.00 $120.00 | 8 | |
An oral retinoid that could possibly activate RARRES1 by binding to retinoic acid receptors, used primarily for severe acne. | ||||||
Acitretin | 55079-83-9 | sc-210754 | 25 mg | $151.00 | 1 | |
A second-generation retinoid that activates retinoic acid receptors which could possibly activate RARRES1 expression, used for psoriasis. | ||||||
Bexarotene | 153559-49-0 | sc-217753 sc-217753A | 10 mg 100 mg | $55.00 $250.00 | 6 | |
A synthetic retinoid that selectively activates retinoid X receptors, which could possibly activate RARRES1 expression, used in cutaneous T-cell lymphoma. | ||||||
Adapalene | 106685-40-9 | sc-203803 sc-203803A | 10 mg 50 mg | $66.00 $332.00 | 2 | |
A synthetic retinoid-like compound that could possibly activate RARRES1 by modulating gene expression through retinoid receptors, primarily used for acne treatment. | ||||||
Vitamin A | 68-26-8 | sc-280187 sc-280187A | 1 g 10 g | $385.00 $2654.00 | ||
A form of vitamin A that can be converted to retinoic acid in the body, which could possibly enhance RARRES1 expression by activating retinoid receptors. | ||||||
all-trans Retinal | 116-31-4 | sc-210778A sc-210778 | 250 mg 1 g | $129.00 $379.00 | 7 | |
An aldehyde form of vitamin A that can be oxidized to retinoic acid in vivo, potentially leading to RARRES1 expression which could possibly be activated. | ||||||
4-Hydroxyphenylretinamide | 65646-68-6 | sc-200900 sc-200900A | 5 mg 25 mg | $104.00 $315.00 | ||
A synthetic retinoid that could possibly modulate RARRES1 by binding to retinoic acid receptors, with potential applications in cancer therapy. | ||||||
Palmitic Acid | 57-10-3 | sc-203175 sc-203175A | 25 g 100 g | $114.00 $286.00 | 2 | |
While not a retinoid, it is a fatty acid that could possibly influence cell signaling pathways and affect the expression of genes like RARRES1. | ||||||